S&P 500 Healthcare Sector SEC Filings — March 16, 2026

16-03-2026

SAIC reported Q4 FY26 revenues of $1.75B, down 5% YoY from $1.838B, and full FY26 revenues of $7.26B, down 3% YoY from $7.479B, primarily due to contract completions, volume ramp-downs, and government shutdown impacts. While adjusted EBITDA margins improved to 10.3% in Q4 (up 70bps) and 9.7% for FY26 (up 20bps), supported by lower SG&A and other recoveries, Q4 net bookings were weak at $0.6B with a 0.3 book-to-bill ratio. FY27 guidance anticipates revenues of $7.0-7.2B with organic growth of -4% to -2%, adjusted EBITDA of $705-715M, and adjusted diluted EPS of $9.50-9.70.

• ·Q4 net bookings $0.6B with book-to-bill 0.3; FY net bookings $7.8B with book-to-bill 1.1.
• ·FY26 share repurchases $422M (4.0M shares); Q4 repurchases $97M.
• ·Quarterly dividend $0.37/share payable April 24, 2026 to record April 10, 2026.
• ·Notable Q4 awards: $629M from Space and Intelligence Community; $95M GAO TIS contract (5-year).
• ·Post-period awards: $330M Space/IC recompete (7-year); $200M Federal Civilian recompete (5-year).
• ·Weighted-average diluted shares: Q4 45.4M (down from 49.0M); FY 46.5M (down from 50.5M).

16-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 16, 2026, announcing via attached press release (Exhibit 99.1) the cancellation of a previously proposed increase in authorized shares following a reverse stock split. The disclosure is furnished under Item 8.01 and not deemed 'filed' for liability purposes. The report was signed by CEO Steven Reinharz.

16-03-2026

Alto Neuroscience reported a net loss of $63.2M for the year ended December 31, 2025, widening 3% YoY from $61.4M, primarily due to lower interest income, interest expense, and a $0.7M loss on debt extinguishment, despite a 3% reduction in total operating expenses to $66.4M from $68.6M. Cash and equivalents increased 5% to $176.5M, bolstered by $60.1M in financing activities including a private placement, though net cash used in operations rose 9% to $51.8M. Stockholders' equity remained nearly flat at $151.1M, down slightly from $151.5M.

• ·Term loan increased to $16.7M non-current from $10.3M.
• ·Stock-based compensation expense rose to $8.1M from $7.6M.
• ·Private placement proceeds $50.0M net of costs.
• ·IPO in 2024 raised $133.0M net.
• ·Total liabilities increased to $33.5M from $26.1M.

16-03-2026

News Corporation disclosed updates provided to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program, authorizing the acquisition of up to $1B in aggregate of Class A (NWSA) and Class B (NWS) common stock. The company provides daily transaction disclosures to the ASX under its rules, with Exhibits 99.1 and 99.2 containing the specific information shared on respective dates. These disclosures include forward-looking statements on repurchase intentions, subject to market conditions and other factors.

16-03-2026

Capital One Financial Corporation filed a Form 8-K on March 13, 2026 (filing date March 16, 2026), furnishing monthly charge-off and delinquency metrics as of and for the month ended February 28, 2026, under Regulation FD Disclosure (Item 7.01). The metrics are detailed in Exhibit 99.1, which is not deemed 'filed' for liability purposes. No specific numerical data on charge-offs or delinquencies is provided in the filing body.

• ·Commission File Number: 001-13300
• ·IRS Employer Identification No.: 54-1719854
• ·Principal executive offices: 1680 Capital One Drive, McLean, Virginia 22102
• ·Telephone: (703) 720-1000

16-03-2026

Truist Financial Corp's DEFA14A filing outlines voting items for its upcoming annual shareholder meeting, including the election of twelve directors for one-year terms expiring at the 2027 Annual Meeting, an advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditors for 2026, and approval of the amendment and restatement of the 2022 Incentive Plan; the board recommends FOR on all except a shareholder proposal on risks from policy misalignment with customer base, which it opposes. No financial metrics or performance data are provided in the filing. Shareholders can request meeting materials online, by phone, or email prior to April 14, 2026.

• ·Material request deadline: April 14, 2026
• ·Voting platform: www.ProxyVote.com or 1-800-579-1639

16-03-2026

New Era Energy & Digital, Inc. (formerly Roth CH V Holdings, Inc., New Era Helium Inc., and others) filed a DEF 14A proxy statement on March 16, 2026, for a virtual Special Meeting of stockholders on April 15, 2026, at 10:00 a.m. ET, to approve the issuance of excess shares of common stock pursuant to Nasdaq Rules 5635(a) and 5635(b) under a Membership Interest Purchase Agreement dated January 16, 2026, with SharonAI, Inc., and an adjournment proposal if needed. As of the record date of March 3, 2026, 56,575,187 shares of common stock ($0.0001 par value) are outstanding, requiring a quorum of 18,896,113 shares (one-third). The Board, led by Chairman and CEO E. Will Gray II, recommends voting FOR both proposals.

• ·Special Meeting access: Toll-free US/Canada +1 800-450-7155, international +1 857-999-9155, Conference ID 3858702#, webcast https://www.cstproxy.com/neweraenergydigital/sm2026
• ·Proposals are non-routine; brokers lack discretion to vote without instructions; abstentions treated as votes against
• ·Company address: 200 N. Loraine Street, Suite 1324, Midland, TX 79701 (updated from filing header 4501 Santa Rosa Dr.)
• ·Proxy materials available at www.proxyvote.com

16-03-2026

Baxter International Inc. announced the departure of EVP and CFO Joel Grade to prioritize family matters, with him continuing in an advisory role until April 30, 2026. Anita Zielinski, who joined in 2025 as SVP, Chief Accounting Officer and Controller, has been appointed interim CFO effective immediately while the company searches for a permanent replacement. Baxter is reiterating its full-year 2026 financial outlook originally provided on February 12, 2026, signaling continuity amid the transition.

• ·Anita Zielinski previously served as SVP and CFO, U.S. Foodservice Operations at Sysco Corporation and spent over 20 years at Ernst & Young LLP as an audit partner.
• ·Media Contact: Stacey Eisen, (224) 948-5353; Investor Contact: Kevin Moran, (224) 948-3085

16-03-2026

Klotho Neurosciences, Inc. merged its wholly-owned subsidiary, GML Subsidiary Corp., into itself pursuant to Section 253 of the Delaware General Corporation Law, resulting in a name change to Greenland Mines Ltd. The merger was approved by unanimous written consent of the Board of Directors on March 9, 2026, and became effective at 5:00 PM on March 11, 2026. No financial impacts or operational changes were disclosed in the filing.

• ·Parent corporation (Klotho Neurosciences, Inc.) incorporated on March 16, 2021
• ·Subsidiary (GML Subsidiary Corp.) incorporated on March 5, 2026
• ·Certificate of Ownership and Merger signed on March 9, 2026
• ·SEC 8-K filed on March 16, 2026 covering Items 5.03, 7.01, 8.01, 9.01

16-03-2026

HeartSciences Inc. reported a narrowed net loss of $6.4M for the nine months ended January 31, 2026, compared to $6.7M prior year (-4% improvement), driven by reduced R&D expenses (-32% YoY to $2.4M) while SG&A rose 18% to $3.5M; cash and equivalents surged 209% to $3.4M, bolstered by $8.1M in financing inflows including $5.5M from Series D preferred stock. However, revenue remained negligible at $4K for the nine months (vs $0), with no revenue in Q3, and total liabilities increased to $4.9M amid higher notes payable. Stockholders' equity improved significantly to $2.7M from $0.2M, supported by equity issuances and conversions.

• ·Common shares outstanding increased to 3,184,207 from 1,119,107 at Apr 30, 2025.
• ·Warrants outstanding rose to 2,102,659 with weighted average exercise price $9.64.
• ·Inventory remained flat at ~$657K; property and equipment net declined to $46K from $64K.

16-03-2026

InPoint Commercial Real Estate Income, Inc. announced its NAV per share of $13.9299 as of February 28, 2026, with total NAV attributable to common stock of $140.97M across 10.12M outstanding shares. Key assets include commercial mortgage loans at $336.7M and real estate owned at $99.4M, offset by liabilities such as repurchase agreements ($206.6M), loan participations sold ($47.7M), and preferred stock ($89.3M). The public offering terminated on November 1, 2025, and no prior period NAV is provided for comparison.

• ·NAV per share by class: Class P $13.9182, Class A $13.9660, Class T $14.1028, Class D $13.9946, Class I $13.9678.
• ·No Class S shares sold or outstanding as of February 28, 2026.
• ·Stockholder servicing fees apply only to Class T, S, and D shares; recognized as NAV reduction monthly but accrued fully under GAAP at sale.

16-03-2026

Associated Banc-Corp's DEF 14A proxy statement, filed March 16, 2026, solicits votes for its virtual Annual Meeting on April 28, 2026, including election of 10 director nominees, advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditors for the year ending December 31, 2026. The record date is March 5, 2026, with 165,333,570 shares of common stock outstanding. No financial performance metrics, period-over-period changes, or material positives/negatives are disclosed in the filing.

• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/ASB2026 at 11:00 a.m. CDT on April 28, 2026.
• ·Voting deadline: 11:59 p.m. ET on April 27, 2026 via internet or telephone.
• ·Proxy materials and 2025 Form 10-K available at http://materials.proxyvote.com/045487.

16-03-2026

Bayview Acquisition Corp deposited $50,000 into its trust account on March 16, 2026, to extend the deadline for consummating its initial business combination by one month, from March 19, 2026, to April 19, 2026. This marks the fourth of up to six permitted extensions under the company's Second Amended and Restated Articles of Association.

• ·Securities registered: Units (BAYAU), Ordinary Shares par value $0.0001 (BAYA), Rights (BAYAR), all on The Nasdaq Stock Market LLC.
• ·Company is an emerging growth company.

16-03-2026

ACRC Lender LLC, a subsidiary of Ares Commercial Real Estate Corp (ACRE), entered into an amendment to its secured revolving funding facility with City National Bank on March 10, 2026, extending the maturity date to December 31, 2026, in exchange for a renewal fee. The amendment qualifies as a material definitive agreement and creates a direct financial obligation. No specific details on the facility size, fee amount, or other terms were disclosed.

16-03-2026

Bowhead Specialty Holdings Inc. (BOW) has filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on April 30, 2026, at 10:00 a.m. ET, where shareholders will vote on electing four Class II directors for a three-year term expiring in 2029 and ratifying PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2026. The record date is March 3, 2026, with 32,838,035 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Annual Meeting voting deadline: 11:59 p.m. ET on April 29, 2026
• ·Company address: 452 Fifth Avenue, New York, New York 10018
• ·Proxy materials available at https://www.virtualshareholdermeeting.com/BOW2026

16-03-2026

Moderna, Inc. filed Definitive Additional Proxy Soliciting Materials (DEFA14A) on March 16, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing appears to include a notice of internet availability of proxy materials (image reference: a2026noticeandaccess_1a.jpg), with no specific proposals, financial data, or performance metrics disclosed in the text.

• ·CIK: 0001682852
• ·EIN: 813467528
• ·SIC: 2836 (Biological Products)
• ·Business address: 325 Binney Street, Cambridge, MA 02142
• ·Business phone: 617-714-6500
• ·Fiscal year end: December 31
• ·SEC file number: 001-38753
• ·State of incorporation: Delaware
• ·Former name change: Moderna Therapeutics, Inc. to Moderna, Inc. on August 22, 2016

16-03-2026

Bally's Corporation reported preliminary Q4 2025 revenue of $746.2M, up 28.6% YoY, driven by strong growth in North America Interactive (+55.4% to $62.3M) and Bally's Intralot B2C (+13.9% to $236.5M), while Casinos & Resorts rose 12.9% to $366.2M but with Adjusted EBITDAR growth lagging at +5.6% to $85.3M due to new competition and cost allocations. The year featured transformative events including the October Intralot acquisition, new NY casino license, and debt refinancing, though results are preliminary and subject to revision with a Form 10-K extension. Full year 2025 revenue approximated $2.66B (Successor + Predecessor), slightly above 2024's $2.45B.

• ·Bally’s holds 58% controlling interest in Bally’s Intralot.
• ·Divestiture of Asia interactive business in Oct 2024 generated $14.1M Q4 2024 revenue.
• ·UK remote gaming duty increase effective April 2026.
• ·Investment converted to 38% equity interest in The Star Entertainment Group.
• ·Form 10-K filing extension via Form 12b-25.

16-03-2026

Corebridge Financial, Inc. disclosed that Minoru Kimura, a director designated by Nippon Life Insurance Company, will depart the Board effective April 20, 2026, due to Nippon's routine personnel rotations, with no disagreements on company matters. Under the December 9, 2024 Stockholder’s Agreement, Nippon retains the right to designate three directors as of March 16, 2026, including sitting directors Keith Gubbay and Tomohiro Yao, and plans to name a replacement for Kimura. The Company will appoint the replacement pending Board review for fiduciary compliance.

• ·Nippon's director designation right under Stockholder’s Agreement applies until its share ownership falls below 5%
• ·Departure notification received on March 11, 2026
• ·Event reported and filing dated March 16, 2026

16-03-2026

SMART Financial Inc. reported strong 2025 financial results with net income up 39% YoY to $50.3M ($2.98 diluted EPS) from $36.1M, driven by net interest income growth of 21% to $166.1M and total assets expanding 11% to $5.86B alongside loans up 12% to $4.36B. However, noninterest income was essentially flat at $34.4M, goodwill and intangibles declined 9% to $95.3M, and provision for loan losses rose 50% to $7.8M amid slightly higher nonperforming assets at 0.22%. Performance ratios improved with ROA at 0.91% and efficiency ratio at 65.5%, though dividends per share remained flat at $0.32.

• ·Tax equivalent net interest margin improved to 3.29% in 2025 from 3.04% in 2024.
• ·Common equity Tier 1 capital ratio at 9.83% in 2025, slightly up from 9.76% in 2024.
• ·Net charge-offs stable at (0.08)% of average loans in both 2025 and 2024.
• ·Book value per share rose to $32.44 in 2025 from $29.04 in 2024.

16-03-2026

Western New England Bancorp, Inc. (WNEB) reported total assets of $2.74B as of December 31, 2025, up 3.1% YoY from $2.65B, supported by net loans growth of 5.5% to $2.16B and deposits increase of 4.4% to $2.36B. Net income surged 30.9% YoY to $15.3M with basic EPS rising to $0.76 from $0.56, driven by net interest income expansion of 17.2% to $70.1M. However, cash and cash equivalents declined 39.2% to $40.4M, non-interest expenses rose 7.0% to $62.5M, and total investment securities were essentially flat at $365.2M.

• ·Basic EPS $0.76 in 2025 (up from $0.56 in 2024); dividends per share steady at $0.28.
• ·Provision for credit losses $335k in 2025 vs reversal of $665k in 2024.
• ·Common stock repurchased: 629,542 shares in 2025 for $6.2M.
• ·Accumulated other comprehensive loss improved to $(16.7M) from $(23.3M).

16-03-2026

VICI Properties Inc. issued its 2026 Proxy Statement for the April 28, 2026 annual stockholder meeting (record date March 2, 2026), seeking approval for election of seven director nominees (86% independent), ratification of Deloitte & Touche LLP as independent auditors, and a non-binding advisory vote on named executive officer compensation. The Board emphasizes strong governance including separate independent Chair and CEO roles, annual director elections, majority voting, proxy access, full compliance with 5x stock ownership guidelines, and 100% attendance at least 75% of meetings; no declines or flat metrics in governance compliance are noted.

• ·Director tenure mix: three directors with 9 years, two with 8 years, one with 6 years as of proxy date
• ·Director retirement policy: resignation offered upon turning 75 prior to next annual meeting
• ·Stock ownership guidelines: 5x annual cash retainer for all directors
• ·Opted out of Maryland Unsolicited Takeover Act (MUTA), Business Combination Statute, and Control Share Acquisition Statute
• ·100% offset of Scope 2 emissions via renewable energy credits (RECs) for 2024 and 2025

16-03-2026

MetroCity Bankshares, Inc. reported net income of $68.5M for 2025, up 6% YoY from $64.5M in 2024, driven by net interest income growth of 10% to $130.4M and total revenue up 10% to $155.6M, with net interest margin expanding to 3.72%. However, ROE declined to 15.60% from 16.16% YoY, efficiency ratio worsened to 40.64% from 37.80% due to $4.7M in First IC merger-related expenses, and tangible book value per share slightly decreased to $16.50 from $16.59.

• ·Average total assets grew to $3.71B in 2025 from $3.57B in 2024.
• ·Noninterest-bearing deposits stable at $549M in 2025 vs $536M in 2024.
• ·Net interest spread expanded to 2.88% in 2025 from 2.61% in 2024.
• ·Shares outstanding increased to 28.8M from 25.4M due to merger.

16-03-2026

Rallybio Corp (RLYB) reported collaboration revenue of $0.858M for FY 2025, up 35% YoY from $0.636M. Operating expenses fell 44% to $33.9M, with R&D down 53% to $19.6M and G&A down 27% to $14.3M, resulting in a reduced net loss of $9.0M from $57.8M, boosted by $22.8M gain on joint venture sale and higher other income. However, the company remains unprofitable with ongoing cash burn of $29.8M from operations and total assets declining to $62.3M from $68.1M.

• ·Net loss per share improved to $(1.59) from $(10.61) YoY.
• ·Weighted-average shares outstanding: 5,629,370 in FY2025 vs 5,443,332 in FY2024.
• ·Stockholders' equity: $57.956M at Dec 31, 2025 vs $61.654M at Dec 31, 2024.
• ·Proceeds from sale of common stock received from JV sale: $20M in FY2025.

16-03-2026

Peoples Financial Services Corp. (PFIS) furnished its 2025 Investor Presentation (March 2026) as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure, making it available on the investor relations section of its website (https://ir.psbt.com/investor-resources/presentations/default.aspx) in anticipation of investor meetings during 2026. The company states that all information in the presentation is as of the dates indicated and disclaims any obligation to update it or infer its materiality. No financial results or performance metrics are disclosed in the filing itself.

16-03-2026

Crypto wealth management platform Abra Financial Holdings, Inc. announced a merger with blank-check firm New Providence Acquisition Corp. III via a Business Combination Agreement dated March 16, 2026, at a $750M pre-money equity value, with the combined company expected to list on Nasdaq under Abra Financial Holdings. Existing investors including Pantera Capital and Adams Street will roll 100% of their interests. However, Abra settled regulatory allegations with the SEC in 2024 over its wound-down Abra Earn lending product and with 25 state regulators for unlicensed operations.

• ·Abra is a registered investment adviser offering services to registered investment advisers, private clients, family offices and hedge funds
• ·SEC Form S-4 Registration Statement to be filed, including proxy statement/prospectus
• ·Filing date: March 16, 2026

16-03-2026

Primis Financial Corp. (FRST) filed its 10-K annual report on March 16, 2026, including a comprehensive glossary of acronyms and terms relevant to its operations such as ACL, CECL, and NII. The filing highlights key risk factors, including challenges in realizing cost savings and revenue enhancements from potential bank acquisitions, risks to deferred tax assets from lower future taxable income or tax rate changes, and the cyclical nature of mortgage revenue sensitive to interest rates and housing market slowdowns. It also details accounting policies for promotional loans, where no interest is recognized until the promotional period expires, and a derivative instrument related to performance fees and interest reimbursement from third-party originators/servicers (TPOS).

16-03-2026

Kingsway Financial Services Inc. announced on March 16, 2026, that its Board of Directors elected Adam J. Patinkin as Chairman, with Terence M. Kavanagh, who served as Chairman for the past twelve years, remaining on the Board as Vice-Chairman. The information was disclosed via a press release furnished as Exhibit 99.1 under Regulation FD.

• ·Common Stock trades under symbol KFS on the New York Stock Exchange
• ·Principal executive offices: 10 S. Riverside Plaza, Suite 1520, Chicago, IL 60606
• ·Registrant’s telephone number: (312) 766-2138

16-03-2026

Tompkins Financial Corporation announced the appointment of Phillip M. Quintana as President-Elect of Tompkins Community Bank, effective March 16, 2026. Mr. Quintana will assume the role of President in or about July 2026 upon the retirement of John M. McKenna, the current President of Tompkins Community Bank and Executive Vice President of the Company. This represents a planned leadership transition with no financial impacts disclosed.

16-03-2026

Elicio Therapeutics, Inc. entered into an At Market Issuance Sales Agreement dated March 16, 2026, with B. Riley Securities, Inc., JonesTrading Institutional Services LLC, and Ladenburg Thalmann & Co. Inc., enabling the company to issue and sell shares of its common stock (par value $0.01 per share) from time to time through the agents as principals or sales agents. Sales are capped at the Maximum Amount, defined as the lesser of limits under the effective Form S-3 registration statement (File No. 333-293861), prospectus supplement, authorized but unissued shares, and Form S-3 General Instruction I.B.6. No specific aggregate dollar amount or share volume was disclosed, and no sales have occurred under the agreement as of the filing.

• ·Agreement filed as Exhibit 10.1 to 8-K.
• ·Sales to be effected pursuant to Registration Statement on Form S-3 (File No. 333-293861).
• ·Agents to receive compensation per Schedule 2 (details not specified in excerpt).

16-03-2026

Smith & Nephew reported FY2025 revenue of $6,164M, up 6.1% reported (5.3% underlying) from $5,810M in 2024, with all three business units achieving >5% underlying growth; operating profit rose 20.7% to $794M (margin +160bps to 12.9%), trading profit increased 15.5% to $1,211M (margin +160bps to 19.7%), cash from operations grew 24.4% to $1,549M, and free cash flow surged 52.5% to $840M. However, adjusted ROIC improved only 90bps to 8.3% due to a -160bps headwind from portfolio rationalization, and US Knee Implants (under 9% of revenue) continue to underperform requiring focus. The company completed its 12-Point Plan transformation and launched the RISE strategy targeting 6-7% organic revenue CAGR and >$1B free cash flow by 2028.

• ·Portfolio rationalization caused -160bps headwind to adjusted ROIC.
• ·US Knee Implants represent <9% of Group revenue and remain a priority for improvement.
• ·Orthopaedics underlying growth improved to 5.1% in FY2025 from 1.9% in 2022.
• ·Acquired Integrity Orthopaedics in January 2026 for rotator cuff repair system.
• ·On track for $325-375M gross cost savings from manufacturing and procurement.
• ·Free cash flow increased 15x from $56M in 2022 to $840M in 2025.
• ·Trading profit margin expanded 240bps from 17.3% in 2022 to 19.7% in 2025.
• ·Revenue CAGR 5.7% over 2022-2025.
• ·Adjusted ROIC up 170bps from 6.6% in 2022 to 8.3% in 2025.
• ·Markets served worth >$50B annually.
• ·AGM scheduled for May 2026.
• ·LANDMARK Knee System launch planned for H2 2026.

16-03-2026

Tianci International reported fiscal Q2 2026 (ended Jan 31, 2026) total revenue of $3.9M, up 87% YoY from $2.1M, driven by 22% growth in global logistics services to $2.5M and initial mineral ore sales of $1.3M. However, net loss widened to $417K from $111K YoY (276% worse) due to cost of revenues surging 90% to $3.8M, logistics gross margin dipping to 3.5% from 3.6%, and G&A expenses more than doubling to $462K; cash balance fell 70% to $723K over six months. The company is shifting focus to long-distance shipping and mineral trading to counter weak Southeast Asia demand.

• ·Accounts receivable increased $562K to $562K as of Jan 31, 2026.
• ·Inventory rose to $517K from $215K at Jul 31, 2025.
• ·Total assets declined to $2.7M from $3.1M at Jul 31, 2025.
• ·Series B Preferred shares converted to 0 from 80,000 during six months.
• ·Operating cash flow used $1.7M in six months FY2026 vs $158K prior year.

16-03-2026

Bridgewater Bancshares, Inc. issued definitive additional proxy materials for its 2026 Annual Meeting on April 28, 2026, at 2:00 PM Central Time, virtually at www.virtualshareholdermeeting.com/BWB2026. Shareholders are asked to vote on electing 11 director nominees, approving on an advisory basis the compensation of named executive officers, approving the 2026 Equity Incentive Plan, and ratifying RSM US LLP as independent auditors for the year ending December 31, 2026; the board recommends 'For' all items. No financial performance metrics or period-over-period comparisons are included in this filing.

• ·Vote deadline: April 27, 2026, 11:59 PM ET
• ·Request proxy materials by April 14, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
• ·Company address: 4450 Excelsior Blvd., Suite 100, St. Louis Park, MN 55416

16-03-2026

Security National Financial Corp (SNFCA) reported total assets of $1.56B as of December 31, 2025, up 4.5% YoY from $1.49B, with total investments growing 7.5% to $1.04B and stockholders' equity increasing 7.5% to $410M. However, cash and cash equivalents declined 27% to $102M, policyholder account balances fell slightly 1.5% to $141M, and insurance premiums remained flat at $120M. The insurance segment saw revenues rise 5% to $208M and net earnings up 7% to $29M.

• ·Fixed maturity securities at $383M (2025) vs $367M (2024).
• ·Mortgage loans held for investment at $322M (2025) vs $302M (2024).
• ·Real estate held for investment at $215M (2025) vs $198M (2024).
• ·Bank and other loans payable declined to $98M from $107M.
• ·Numerous leased mortgage sales offices across multiple states with monthly lease costs ranging from $141 to $49,277 and various expiration dates through 2030.

16-03-2026

Consolidated net sales rose 8.3% YoY to $925.3M for FY2025 ended January 3, 2026, driven by the Hiya direct-to-consumer acquisition which contributed $132.0M (up from $2.0M), while core nutritional sales declined 8.3% to $775.5M amid currency headwinds and local currency drops like -7.4% in China. Gross profit margin contracted to 78.3% from 81.1%, and operating margin fell sharply to 4.0% from 7.7% due to higher cost of sales (21.7% vs 18.9%) and cost realignment expenses. Cash and equivalents decreased to $158.4M from $181.8M.

• ·Product mix stable: Nutritionals Optimizers at 71% of core sales for three years; Essentials/CellSentials flat at 16%; Foods declined slightly to 6% from 7%; Personal care rose to 6% from 5%.
• ·Hiya DTC products: Kids Daily Multivitamin 54% of sales (down from 55%), Kids Daily Probiotic 14% (down from 15%).
• ·Regional core sales declines: Southeast Asia Pacific -10.1% reported/-11.4% ex-FX; North Asia -9.7%/-5.8%; Americas/Europe -8.9%/-7.8%.
• ·Cash breakdown: China $89.3M (down from $101.2M), US $28.5M (down from $43.0M), other $40.6M (up from $37.6M).